Solr Search

alled tau—a common culprit in a number of neurodegenerative diseases—we make the case that focused strategic investment in tau research and the , At present, no disease-modifying therapies for the pure tauopathies exist. Researchers are working to develop effective therapeutic agents, which include approaches such as decreasing the amount of tau within the brain., Symptomatic Interventions At present, no disease-modifying therapies for the pure tauopathies exist.

idance to high- and ultra-high-net-worth philanthropis

ces advocating for philanthropists to expand the scale of their social investments by unlocking the resources being held in donor-advised funds (DAFs).

d with a crisis that's unlike anything most of us have seen in our lifetimes.